Chemoinformaics analysis of 6,6-DIMETHYL-5-METHYLIDENEBICYCLO[2.2.1]HEPTAN-2-ONE
| Molecular Weight | 150.221 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 23 |
| Exact Molecular Weight | 150.104 | nRing | 2 |
| Solubility: LogS | -3.03 | nHRing | 0 |
| Solubility: LogP | 0.409 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 26.8371 |
| nHD | 0 | BPOL | 14.9129 |
| QED | 0.318 |
| Synth | 4.426 |
| Natural Product Likeliness | 2.122 |
| NR-PPAR-gamma | 0.071 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.68 |
| HIA | 0.872 |
| CACO-2 | -5.792 |
| MDCK | 0.000031 |
| BBB | 0.144 |
| PPB | 0.958143 |
| VDSS | 1.086 |
| FU | 0.0470684 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.425 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.841 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.566 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.368 |
| CYP3a4-inh | 0.047 |
| CYP3a4-sub | 0.648 |
| CL | 7.253 |
| T12 | 0.319 |
| hERG | 0.027 |
| Ames | 0.437 |
| ROA | 0.148 |
| SkinSen | 0.031 |
| Carcinogencity | 0.055 |
| EI | 0.009 |
| Respiratory | 0.163 |
| NR-Aromatase | 0.878 |
| Antiviral | No |
| Prediction | 0.92619 |